0001415889-24-006594.txt : 20240305 0001415889-24-006594.hdr.sgml : 20240305 20240305161549 ACCESSION NUMBER: 0001415889-24-006594 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240301 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jorgensen Nathan D. CENTRAL INDEX KEY: 0001842523 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39979 FILM NUMBER: 24720599 MAIL ADDRESS: STREET 1: C/O VOR BIOPHARMA INC. STREET 2: 100 CAMBRIDGEPARK DRIVE, SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vor Biopharma Inc. CENTRAL INDEX KEY: 0001817229 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CAMBRIDGEPARK DRIVE STREET 2: SUITE 101 CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-655-6580 MAIL ADDRESS: STREET 1: 100 CAMBRIDGEPARK DRIVE STREET 2: SUITE 101 CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 form4-03052024_040329.xml X0508 4 2024-03-01 0001817229 Vor Biopharma Inc. VOR 0001842523 Jorgensen Nathan D. C/O VOR BIOPHARMA INC. 100 CAMBRIDGEPARK DRIVE, SUITE 101 CAMBRIDGE MA 02140 false true false false CHIEF FINANCIAL OFFICER 0 Common Stock 2024-03-01 4 F 0 6310 2.27 D 191154 D Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. /s/ Katie Kazem, Attorney-in-Fact 2024-03-05